Mission
Governance
Administration
Policies
MISSION
Preventive molecular medicine for chronic diseases
The decodification of the human genome sequence more than a decade ago has opened the greatest gap between the accumulation of scientific information and the possibility of translating this into new therapies or diagnostics. Hence, the need for more “translational” research and for a greater capacity to network between research organizations. INGM aims at strengthening European biomedical research in these two key points.
INGM biomedical research is based on “state of the art” technological platforms with strong connections to clinical needs. The presence among the founders of INGM of IRCCS Ospedale Maggiore of Milan and its location within the University Hospital campus facilitates the establishment of more clinically oriented research programs. In Europe, INGM collaborates with international institutes on the base of common, equally shared research programs funded by EU agencies. In the entrepreneurial sector, INGM collaborates, on the basis of Intellectual Property sharing, with several biotech companies, so as to reinforce the translational link of technological innovation.
INGM is an advanced research center, which creates a well-defined niche of activities in the field of human “omics” research. Through a diversified research network of public and private collaborations, INGM develops research projects aimed at identifing new biomarkers and new therapeutic targets that could improve the secondary prevention of chronic diseases (infectious, autoimmune or neoplastic). With the continuous aging of the population, secondary prevention is becoming a key factor for more sustainable health programs of our societies.
Thus, INGM strives to translate new discoveries into new diagnostic and new therapies aimed at reducing morbidity and mortality caused by chronic diseases, with the big objectives of improving quality of life while making public health more sustainable.
INGM RESEARCHES ARE SUPPORTED BY
ABOUT INGM
Lorem ipsum dolor sit amet, munere platonem constituto vis eu
Ei dolores intellegat disputationi sit, mel oblique vivendo ancillae ex. Duo ad dolores insolens accusamus, vim utinam oporteat expetendis an. Eam delenit commune moderatius id. Cu cum everti appareat splendide. Eros dissentiunt delicatissimi eam at.
Eum justo feugiat epicuri an. Natum molestiae an eum. Quo atqui ubique nemore id, in mei clita veniam officiis. Ut mollis consetetur per, impetus docendi scribentur et vix, sea erant percipit tincidunt ea. Ius ex detracto moderatius scripserit, ut ius quem conceptam, ut meis quas possim sed.
Sint modus antiopam nec et. Ei quo suas propriae, usu etiam posidonium et. Vix illum admodum invidunt et. Ea sit sanctus ponderum, suas homero aliquando vel te, eripuit aliquando in vis.
Ei liber harum sed, sit ex dicam virtute. Partem nullam forensibus et mea. Assum tibique argumentum sea at, sit ei electram mnesarchum. An odio prima urbanitas mea.
Eos diam viris eruditi ne. Offendit invidunt nominati et eos, his simul discere eu, no graecis instructior nec. Eam dolorem fabellas menandri id, ius discere incorrupte ex, et mollis viderer vix. Ex eam commodo constituam.
NEWS
09.09.2016
Non c’è medicina senza ricerca: ecco la ricetta di Fondazione Cariplo e INGM
ALL NEWS
06.09.2016
Evento teatrale di beneficienza: domenica 25 settembre
20.07.2016
November 16th, 2016.
INGM – Policlinico 3rd Research Day
06.09.2016
Evento teatrale di beneficienza: domenica 25 settembre
